$BCOV
Brightcove Inc

2023 Q2 Form 10-Q Financial Statement

#000095017023017211 Filed on May 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $50.99M $49.06M $53.38M
YoY Change -6.35% -8.09% -2.63%
Cost Of Revenue $18.50M $20.27M $18.98M
YoY Change -1.09% 6.78% -0.99%
Gross Profit $32.49M $28.80M $34.40M
YoY Change -9.11% -16.29% -3.51%
Gross Profit Margin 63.71% 58.69% 64.44%
Selling, General & Admin $28.44M $29.53M $26.38M
YoY Change 7.26% 11.95% 13.64%
% of Gross Profit 87.54% 102.55% 76.68%
Research & Development $10.35M $9.866M $8.237M
YoY Change 23.57% 19.78% -0.52%
% of Gross Profit 31.84% 34.26% 23.95%
Depreciation & Amortization $4.059M $3.949M $2.061M
YoY Change 87.4% 91.61% -4.58%
% of Gross Profit 12.49% 13.71% 5.99%
Operating Expenses $38.78M $39.54M $35.76M
YoY Change 10.68% 10.56% 13.53%
Operating Profit -$6.297M -$10.74M -$1.364M
YoY Change -995.73% 687.68% -132.87%
Interest Expense $422.0K -$543.0K -$387.0K
YoY Change -151.15% 40.31% -47.7%
% of Operating Profit
Other Income/Expense, Net $422.0K -$543.0K -$387.0K
YoY Change -151.15% 40.31%
Pretax Income -$5.920M -$11.29M -$2.345M
YoY Change 4752.46% 381.32% -143.51%
Income Tax $317.0K $427.0K -$708.0K
% Of Pretax Income
Net Earnings -$6.237M -$11.71M -$1.637M
YoY Change 1972.09% 615.58% -131.91%
Net Earnings / Revenue -12.23% -23.88% -3.07%
Basic Earnings Per Share -$0.14 -$0.28 -$0.04
Diluted Earnings Per Share -$0.14 -$0.28 -$39.51K
COMMON SHARES
Basic Shares Outstanding 42.86M 42.33M 41.44K
Diluted Shares Outstanding 43.06K 42.53K 41.44K

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $19.09M $12.48M $26.71M
YoY Change -31.33% -53.27% -24.13%
Cash & Equivalents $43.00K $12.48M $41.00K
Short-Term Investments
Other Short-Term Assets $22.28M $11.51M $21.84M
YoY Change 115.24% -47.28% -3.79%
Inventory
Prepaid Expenses $9.804M $9.786M
Receivables $29.85M $40.62M $34.04M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $71.22M $74.40M $82.58M
YoY Change -12.75% -9.91% -6.58%
LONG-TERM ASSETS
Property, Plant & Equipment $60.60M $42.16M $49.97M
YoY Change 86.24% -15.64% 109.09%
Goodwill $74.86M $74.86M $74.84M
YoY Change 0.03% 0.03%
Intangibles $8.244M $9.261M
YoY Change -31.8%
Long-Term Investments
YoY Change
Other Assets $6.285M $6.750M $6.612M
YoY Change -2.78% 2.09% 8.39%
Total Long-Term Assets $150.0M $151.1M $144.3M
YoY Change 3.46% 4.68% 43.3%
TOTAL ASSETS
Total Short-Term Assets $71.22M $74.40M $82.58M
Total Long-Term Assets $150.0M $151.1M $144.3M
Total Assets $221.2M $225.5M $226.9M
YoY Change -2.38% -0.63% 19.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $15.75M $13.01M $14.03M
YoY Change 31.75% -7.22% 20.92%
Accrued Expenses $24.34M $21.69M $25.80M
YoY Change 6.27% -15.93% 4.46%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $109.7M $110.5M $103.9M
YoY Change 7.53% 6.28% 9.18%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $19.90M $959.0K $22.85M
YoY Change 2168.87% -95.8% 280.87%
Total Long-Term Liabilities $19.90M $959.0K $22.85M
YoY Change 2168.87% -95.8% 280.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $109.7M $110.5M $103.9M
Total Long-Term Liabilities $19.90M $959.0K $22.85M
Total Liabilities $129.6M $131.2M $126.8M
YoY Change 4.63% 3.45% 25.29%
SHAREHOLDERS EQUITY
Retained Earnings -$228.0M -$221.8M
YoY Change 12.33%
Common Stock $43.00K $43.00K
YoY Change 2.38%
Preferred Stock
YoY Change
Treasury Stock (at cost) $871.0K $871.0K
YoY Change 0.0%
Treasury Stock Shares $135.0K
Shareholders Equity $91.60M $94.29M $100.1M
YoY Change
Total Liabilities & Shareholders Equity $221.2M $225.5M $226.9M
YoY Change -2.38% -0.63% 19.98%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$6.237M -$11.71M -$1.637M
YoY Change 1972.09% 615.58% -131.91%
Depreciation, Depletion And Amortization $4.059M $3.949M $2.061M
YoY Change 87.4% 91.61% -4.58%
Cash From Operating Activities $10.81M -$12.63M -$690.0K
YoY Change 8.68% 1730.72% 15.0%
INVESTING ACTIVITIES
Capital Expenditures $3.679M $952.0K -$4.766M
YoY Change -149.03% -119.97% 213.55%
Acquisitions $0.00 $13.18M
YoY Change -100.0%
Other Investing Activities $0.00 $0.00 -$13.18M
YoY Change -100.0% -100.0%
Cash From Investing Activities -$3.679M -$4.882M -$17.94M
YoY Change -51.23% -72.79% 1080.39%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -31.00K -1.925M 100.0K
YoY Change 342.86% -2025.0% -81.13%
NET CHANGE
Cash From Operating Activities 10.81M -12.63M -690.0K
Cash From Investing Activities -3.679M -4.882M -17.94M
Cash From Financing Activities -31.00K -1.925M 100.0K
Net Change In Cash 7.100M -19.42M -18.53M
YoY Change 196.2% 4.77% 1065.53%
FREE CASH FLOW
Cash From Operating Activities $10.81M -$12.63M -$690.0K
Capital Expenditures $3.679M $952.0K -$4.766M
Free Cash Flow $7.131M -$13.58M $4.076M
YoY Change -59.14% -433.27% 343.04%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001313275
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-35429
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
BRIGHTCOVE INC
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-1579162
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
281 Summer Street
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Boston
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02210
CY2023Q1 dei City Area Code
CityAreaCode
888
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
882-1880
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock
CY2023Q1 dei Trading Symbol
TradingSymbol
BCOV
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
42857371
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12478000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31894000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
343000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
294000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
40623000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
26004000
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
9786000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
77320000
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
8700000
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
11513000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
10722000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
42155000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
39677000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18025000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18671000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9261000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
10279000
CY2023Q1 us-gaap Goodwill
Goodwill
74859000
CY2022Q4 us-gaap Goodwill
Goodwill
74859000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6750000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7007000
CY2023Q1 us-gaap Assets
Assets
225450000
CY2022Q4 us-gaap Assets
Assets
227813000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
13014000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
11326000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
21692000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
26877000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
74400000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4218000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8237000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4157000
CY2023Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
71537000
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
61597000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
110461000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
103957000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
19740000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
20528000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
959000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
981000
CY2023Q1 us-gaap Liabilities
Liabilities
131160000
CY2022Q4 us-gaap Liabilities
Liabilities
125466000
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42992371
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42449677
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
43000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
42000
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
318293000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
314825000
CY2023Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
135000
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
135000
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
871000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
871000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1405000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1593000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-221770000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-210056000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
94290000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
102347000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
225450000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
227813000
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
49063000
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
53379000
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
20267000
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
18980000
CY2023Q1 us-gaap Gross Profit
GrossProfit
28796000
CY2022Q1 us-gaap Gross Profit
GrossProfit
34399000
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9866000
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
19465000
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
18288000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10064000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8089000
CY2023Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
145000
CY2022Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
594000
CY2023Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
0
CY2022Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1149000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
39540000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
36357000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-10744000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1958000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-543000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-387000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11287000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2345000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
427000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-708000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-11714000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1637000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42528
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41436
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42528
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41436
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-11714000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1637000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
188000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-243000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11526000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1880000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
94290000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
100094000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-11714000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1637000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3949000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2061000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3543000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3479000
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
67000
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
106000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
14713000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3802000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
986000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
18000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1550000
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-314000
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-54000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
956000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
347000
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3999000
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1980000
CY2023Q1 bcov Increase Decrease In Operating Leases
IncreaseDecreaseInOperatingLeases
-81000
CY2022Q1 bcov Increase Decrease In Operating Leases
IncreaseDecreaseInOperatingLeases
705000
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
10032000
CY2022Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1527000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12632000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-690000
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
13176000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
952000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1884000
CY2023Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
3930000
CY2022Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
2882000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4882000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17942000
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
100000
CY2023Q1 bcov Payments For Deferred Acquisition Payments
PaymentsForDeferredAcquisitionPayments
1700000
CY2022Q1 bcov Payments For Deferred Acquisition Payments
PaymentsForDeferredAcquisitionPayments
0
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-225000
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1925000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
100000
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23000
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-502000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-19416000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-19034000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31894000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
45739000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12478000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26705000
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
874000
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
796000
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
505000
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
216000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
343000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
294000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
67000
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
30500000
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
32800000
CY2023Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
12900000
CY2022Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
12400000
CY2023Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
2500000
CY2022 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
2500000
CY2023Q1 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
12478000
CY2023Q1 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
12478000
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
31894000
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
31894000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.75
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.034
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.048
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.479
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.555
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
39800000
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y9M7D
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3543000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3479000
CY2023Q1 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1000000.0
CY2023Q1 us-gaap Debt Instrument Covenant Description
DebtInstrumentCovenantDescription
If the outstanding principal during any month is at least $15.0 million, the Company must also maintain a minimum net income threshold based on non-GAAP operating measures.
CY2023Q1 us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2023-12-28
CY2023Q1 us-gaap Revenues
Revenues
49063000
CY2022Q1 us-gaap Revenues
Revenues
53379000
CY2023Q1 bcov Percentage Of Revenue
PercentageOfRevenue
0.10
CY2022Q1 bcov Percentage Of Revenue
PercentageOfRevenue
0.10
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
400000

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0000950170-23-017211-index-headers.html Edgar Link pending
0000950170-23-017211-index.html Edgar Link pending
0000950170-23-017211.txt Edgar Link pending
0000950170-23-017211-xbrl.zip Edgar Link pending
bcov-20230331.htm Edgar Link pending
bcov-20230331.xsd Edgar Link pending
bcov-ex31_1.htm Edgar Link pending
bcov-ex31_2.htm Edgar Link pending
bcov-ex32_1.htm Edgar Link pending
bcov-20230331_cal.xml Edgar Link unprocessable
bcov-20230331_def.xml Edgar Link unprocessable
bcov-20230331_pre.xml Edgar Link unprocessable
bcov-20230331_lab.xml Edgar Link unprocessable
bcov-20230331_htm.xml Edgar Link completed
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending